SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05
http://www.w3.org/2000/01/rdf-schema#comment
"Observational study of gene-disease association. (HuGE Navigator); CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) variant alleles were significantly associated with low mean weekly warfarin dose."
xsd:string
http://purl.uniprot.org/uniprot/#_C5718865B7A7A96189633DE74C7F26F7B9D77AD578600D263C0DEF40D098186279C925420C63B732CB0ED241D318A555
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05
http://purl.uniprot.org/uniprot/A0A0A7MA87
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05
http://purl.uniprot.org/uniprot/#_A0A0A7MA87-mappedCitation-18034619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E4C3CC44ACFB7E1C9F2F8D96EC19CEB33DC89C37C4A5EE84CB12D899D486110F74A2ACF4F5C016302337BD9DBC0EFD05